Skip to main content

Table 3 Comparison of resistance rates between A.baumannii strains isolated from patients and from environmental samples to different products tested

From: In vitro evaluation of the susceptibility of Acinetobacter baumannii isolates to antiseptics and disinfectants: comparison between clinical and environmental isolates

Products

Dilution

Origin of the strains

Total (n = 81)

P

Patients (n = 45)

Environment (n = 36)

PVPI

PURE

0% (0)

0% (0)

0% (0)

-

1|3

24.44% (11)

11.11% (4)

18.51% (15)

0.125

1|10

100% (45)

69.44% (25)

86.41%(70)

<0.001

1|100, 1|1000

100% (45)

100% (36)

100% (81)

-

CHX

PURE

0% (0)

0% (0)

0% (0)

-

1|10

13.33% (6)

0% (0)

7.40% (6)

0.31

1|100

51.11% (23)

66.66% (24)

58.02 (47)

0.159

1|1000

100% (45)

100% (36)

100% (81)

-

AL

PURE

0% (0)

0% (0)

0% (0)

-

1|2

37.77% (17)

11.11% (4)

25.92% (21)

0.007

1|10

93.33% (42)

80.55% (29)

87.65% (71)

0.100

1|100, 1|1000

100%(45)

100% (36)

100% (81)

-

DDA

PURE, 1|10,1|100, 1|400

0% (0)

0% (0)

0% (0)

-

1|1000

24.44% (11)

8.33% (3)

17.28% (14)

0.057

10–4

86.66% (39)

69.44% (25)

79.01% (64)

0.059

10–5, 10–6

100% (45)

100% (36)

100%(81)

-

NRP

PURE

24.44% (11)

0% (0)

13.58% (11)

0.001

1|10

66.66% (30)

19.44% (7)

45.67% (37)

<0.001

1|50

97.77% (44)

94.44%(34)

96.29% (78)

0.582

1|100, 1|1000

100% (45)

100% (36)

100% (81)

-

  1. PVPI povidone-iodine, CHX chlorhexidine digluconate, AL ethyl Alcohol, DDA N-(3-aminopropyl)-N-dodécylpropane-1,3-diamine + didecyl dimethyl ammonium chloride, NRP non registered
  2. - : p value not calculated